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Abstract Resistin is a secreted adipose tissue hormone that
belongs to the resistin-like molecule family. We report here a
new alternatively spliced isoform of the rat resistin gene, named
S-resistin (short resistin), detected in adipose tissue by reverse
transcription-polymerase chain reaction (RT-PCR). A compar-
ison of this cDNA variant and genomic sequences indicates the
lack of the second exon containing the secretory consensus sig-
nal. Both cDNAs, resistin and S-resistin, were carboxy-tagged
with FLAG epitope and transiently expressed in cultured cell
lines. While the resistin-FLAG construct gives the expected
pattern for a secretion protein, the S-resistin-FLAG construct
yielded a predominant nuclear staining. These results indicate
that this splicing event regulates the fate and probably the func-
tion of the mature protein.
+ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Resistin is a novel adipose-secreted hormone induced dur-
ing the late stage of adipogenesis and constitutively expressed
in white adipose tissue (WAT) [1^4]. The inhibitory e¡ect of
resistin on adipocyte di¡erentiation suggests that it acts as a
feedback regulator of adipogenesis [5]. Resistin mRNA en-
codes a 114 amino acid polypeptide including a 20 amino
acid signal peptide and a carboxy-terminal cysteine-rich do-
main characteristic of the resistin-like molecule (RELM) fam-
ily. Other members of this family, RELMK and RELML, are
also secreted proteins with tissue-speci¢c distribution. Thus,
RELMK is expressed in lung, tongue and stroma vascular
fraction of adipose tissue, and RELML in epithelial intestine
cells [6^9].
Resistin serum concentration is increased in diet-induced
obese mice and decreased by anti-diabetic drugs [1]. More-
over, in vivo administration of recombinant resistin impairs
glucose tolerance and insulin action in normal mice, while
administration of anti-resistin antibody enhances the insulin
sensitivity of insulin-resistant and obese mice. These facts al-
lowed Steppan et al. [1] to propose that resistin is a hormone
that links obesity to insulin resistance and type II diabetes.
However, several studies have been published supporting the
concept that insulin resistance and obesity are associated with
decreased resistin expression [10^12]. Since the resistin recep-
tor has not yet been isolated and the molecular mechanism of
resistin action still has not been elucidated, its role remains
unclear.
In the process of analyzing the expression of resistin in
adipose tissues from Wistar rats, we found a shorter resistin
cDNA, S-resistin, generated by alternative splicing. This splic-
ing variant eliminates the second exon containing the secre-
tion peptide signal, and could produce a non-secretable
protein. Interestingly, S-resistin is found into nucleus of trans-
fected cell lines, opening the possibility, not reported previ-
ously, that resistin could also play a role as an intracrine
factor in the regulation of adipocyte gene expression and/or
in the adipogenic process.
2. Materials and methods
2.1. Cell culture
Stroma vascular preadipocytes were isolated under sterile condi-
tions from epididymal fat pads of 180^220 g male Wistar rats fed
ad libitum. The fat pads were digested with collagenase according
to the method of Rodbell [13]. The preadipocytes were obtained
and di¡erentiated as previously described [14]. Cells were regarded
as di¡erentiated by morphologic criteria assessed by oil red O stain-
ing. RNA was extracted from preadipocytes and di¡erentiated adipo-
cytes as described below.
2.2. RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA extraction from 3 months old male Wistar rat adipose
tissues and cells was performed as described by Peralta et al. [15] and
Carraro et al. [16] respectively. cDNA synthesis and PCR reactions
were performed as described previously [15]. The primers used for
full-length resistin cDNA PCR ampli¢cation were primer 1 (5P-AG-
TTGTGCCCTGCTGAGCTCTCTGCC-3P) as forward, and primer 4
(5P-CCCATTGTGTATTTCCAGACCCTC-3P) as reverse one. Both
were designed according to the published sequence [5] (accession num-
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ber in the TIGR database: TC119941) and resulted in the ampli¢ca-
tion of a 529 bp fragment. Additional primers were used for cDNA
characterization: primer 2 (5P-CACTGTGTCCCATGGATGAAG-
CC-3P), primer 3 (5P-CCCTCTGGAGACTGACCAGC-3P), and prim-
er 5 (5P-TGAGTCCACTTTACCGTGCATC-3P). Moreover, we de-
signed the primer X (5P-TGAGCTCTCTGCCACGTGCC-3P) as a
forward hybrid primer that contains the 16 last nucleotides from
the ¢rst exon and the four ¢rst nucleotides from the third exon.
The rat actin primers used were as described previously [14]. The
PCR reactions under standard conditions were performed at 1 WM
primer concentration. To amplify resistin cDNAs under non-compet-
itive conditions, the resistin primer concentration in the PCR reaction
was three-fold the standard one. Following reactions, samples were
electrophoresed in 2% agarose gels, and the ampli¢ed bands were
analyzed as described by Peralta et al. [15]. Control reactions with
di¡erent number of cycles have been previously performed to select
conditions of ampli¢cation in the linearity range.
2.3. Construction of plasmids
Ampli¢ed PCR products using primers 1 and 4 were cloned into
pSTBlue-1 plasmid using blunt cloning kit (Novagen) and sequenced
with the ABI Prism 3700 DNA analyzer (Applied Biosystems). An
eight amino acid FLAG epitope tag (peptide DYKDDDDK) was
introduced at the carboxy-terminus immediately preceding the termi-
nation codon as described previously [17]. The carboxy FLAG-tagged
products obtained, S-res-FLAG and res-FLAG, were subcloned into
Fig. 1. Identi¢cation of a novel alternatively spliced rat resistin. A: RT-PCR ampli¢cation of rat resistin mRNAs from WAT using primers 1
and 4 (see Section 2). The 529 bp cDNA corresponds to the resistin variant reported previously [5]; the 389 bp cDNA was identi¢ed as a novel
spliced resistin variant. At the right side, a schematic picture of rat resistin genomic structure and its putative transcripts is shown. White boxes
represent the 5P and 3P untranslated regions, the second alternative exon is indicated as a dashed box, and the third and fourth exons as gray
and black boxes respectively. Arrows show the positions of PCR primers 1 and 4 used. The two potential translation start AUG sites are indi-
cated. Alternative splicing event is denoted by a dashed line. B: S-resistin cDNA sequence. Coding sequences are capitalized. Initial ATG is
shown in bold. The position of primers used is indicated by arrow. The junction points of the splicing process are marked by asterisks (acces-
sion number AJ555618). C: Multiple sequence alignment of resistin proteins. Alignment between rat, human and mouse resistin (accession num-
bers NP653342, NP065148 and NP075360, respectively), and S-resistin variant was performed by ClustalW program (EMBL-EBI, European
Bioinformatics Institute). The endoplasmic reticulum targeting peptides of large isoforms are underlined. Conserved cysteine residues are indi-
cated in bold.
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pCMV5 expression vector to ¢nally obtain pCMV5-S-res-FLAG and
pCMV5-res-FLAG.
2.4. Cell line culture and transfection
COS-7 and HEK-293T cells were grown in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) containing 5% fetal bovine serum (FBS)
(Gibco BRL) at 37‡C in a 7% CO2 atmosphere. 3T3-L1 cells (pur-
chased to ATCC) were grown in DMEM complemented with 10%
FBS. Cells were transiently transfected using lipofectamine1 reagent
(Invitrogen). Cells were incubated with DNA^liposome complexes in
serum-free media for 6 h. After 48 h, cells were ¢xed and processed.
2.5. Western blot analysis
Total protein extracts were obtained from transiently transfected
HEK-293T cells. 106 cells were transfected with 20 Wg of each
DNA, and after 36 h were harvested in lysis bu¡er (1% Triton
X-100, 150 mM NaCl, 20 mM Tris^HCl pH 7.5, 0.5 mM ethylenedi-
amine tetraacetic acid (EDTA), 1 mM ethyleneglycol-bis-(L-aminoe-
thylether)-N,N,NP,NP-tetraacetic acid (EGTA) and protease inhibi-
tors), incubated at 4‡C for 15 min and centrifuged a 12 000Ug to
pellet the cell debris. Proteins were separated on 15% tricine^polyac-
rylamide gel electrophoresis (PAGE) gels and transferred to 0.2 Wm
nitrocellulose membranes. Blots were probed with anti-FLAG M2
antibody (1:2000, Sigma), washed and incubated for 30 min with
horseradish peroxidase-conjugated anti-mouse antibody (1:1000,
Bio-Rad). After washing, antigen^antibody complexes were detected
using the enhanced chemoluminescence (ECL) method (Amersham
Pharmacia Biotech).
2.6. Immuno£uorescence analysis and mitochondria-speci¢c staining
For the study of mitochondrial location, living cells were stained
with MitoTracker Red CMXRos (200 nM, 30 min, Molecular Probes)
and ¢xed. Immuno£uorescence analysis with anti-Flag M2 antibody
was performed as described previously [17]. Nuclear staining with
Hoechst was performed by incubation with 1 Wg/ml in phosphate-
bu¡ered saline (PBS) at 30 min. Fluorescence microscopy was per-
formed using an axiovert epi£uorescence microscope (Carl Zeiss) at
U100.
3. Results
3.1. Characterization of a novel alternatively spliced variant of
rat resistin gene
During the analysis of resistin expression by RT-PCR in
adipose tissues from young Wistar rats, we have detected
the ampli¢cation of two di¡erent resistin transcripts, the ex-
pected resistin messenger and a shorter PCR fragment not
described previously (Fig. 1A). Since PCR reactions were car-
ried out using speci¢c primers complementary to sequences
upstream to the 5P translation start site and 3P untranslated
region of rat resistin cDNA (primers 1 and 4, see Section 2)
we thought that a process of alternative splicing could ac-
count for the generation of this novel fragment. To check
this hypothesis, both PCR products were cloned and se-
quenced con¢rming that the major one, of 529 bp, contains
the full-length resistin cDNA described by Kim et al. [5],
whereas the minor PCR fragment, of 389 bp, presents identi-
cal sequences at 3P and 5P ends as rat resistin cDNA, but it
contains an internal deletion of 140 nucleotides at its 5P region
(GenBank accession number AJ555618). This structure
strongly suggests that this cDNA molecule represents a new
spliced variant. Alignment analysis using BLAST program
(NCBI) with rat genomic (chromosome 12 supercontig
NW_042768) and cDNA resistin sequences indicates that
£anking nucleotides of divergence point among sequences of
this 389 bp fragment and resistin cDNA perfectly match with
exonic sequences from exon 1/intron 1 and intron 2/exon 3
junctions, con¢rming that entire exon 2 is spliced in the short-
er fragment. Fig. 1A shows the genomic structure of rat re-
sistin gene and the splicing events involved in the generation
of both resistin transcripts. Thus, the 389 bp cDNA contains
the ¢rst non-coding resistin exon, but lacks the second one
containing the AUG start translation codon which encodes
for the 47 ¢rst amino acids of resistin protein including the
20 amino acid peptide signal sequence characteristic of se-
creted proteins (Fig. 1B, C). We have named this novel resis-
tin isoform S-resistin.
A complete characterization of resistin variants performed
with speci¢c primers for each isoform is shown in Fig. 2. To
amplify speci¢cally the S-resistin variant, we realize RT-PCR
analysis using a S-resistin-speci¢c forward primer derived
from exon 1/exon 3 junction (primer X, see Section 2, Fig.
2A and B). As is observed in Fig. 2B (lanes X-4 and X-5),
with S-resistin-speci¢c primer a single PCR fragment corre-
sponding to S-resistin variant is detected. Also, the longer
resistin isoform is speci¢cally obtained with primer derived
from exon 2 sequences spliced in S-resistin (Fig. 2B, lanes
Fig. 2. RT-PCR characterization of resistin cDNA variants. A: Diagram of resistin isoforms with the relative position of the di¡erent primers
used in RT-PCR assays. Numbered primers, one to ¢ve, are represented by arrows. Primer X sequence is indicated, the sequence derived from
the exon 1 3P end is shown in a white box and the sequence from the exon 3 5P sequence in a gray box. B: RT-PCR analysis from WAT
RNA. RT is made with random primers and equivalent aliquots of cDNA are used for PCR ampli¢cation. Primer pairs used in each PCR re-
action are indicated at the top. Molecular weight markers are HindIII-digested P29. The fragment size is indicated in bp. Both resistin and S-re-
sistin sequences are ampli¢ed using a common forward primer (primer 1, lanes 1-4, 1-5 and 1-3). A single fragment is obtained when speci¢c
primers for each isoform are utilized. Primer X for S-resistin variant (lanes X-4 and X-5) and primer 2, derived for the exon 2 sequence, for
the long resistin isoform (lanes 2-4 and 2-3). Identical pattern is obtained with reverse speci¢c primers for the alternative polyadenylated resistin
species described by Kim et al. [5] (primers 4 and 5, lanes 1-4 and 1-5). It shows that resistin and S-resistin use both polyadenylation signals.
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2-4 and 2-3). As a control of this approach, primer X was
used as forward primer to amplify cDNA using the clones
from S-resistin and resistin. Only PCR ampli¢ed cDNA
cloned sequences from S-resistin gave the predicted ampli¢ca-
tion product (data not shown). Furthermore, when PCR re-
action was made in RNA samples without RT no bands were
detected.
The predicted S-resistin open reading frame (ORF) encodes
for a 67 amino acid long protein that conserves the carboxy-
terminal cysteine-rich domain present in the RELM family
(Fig. 1C) [1,5,7]. Its ¢rst available translational start site is
located at the beginning of the third exon (Fig. 1A), and it
corresponds to the internal Met48 residue of resistin (Fig. 1C).
Although rat, mice and human resistin genes show identical
genomic structures and high degree of homology at amino
acid level, this methionine residue is only present in rat resistin
protein (Fig. 1C). The lost N-terminal portion displays a
slightly lesser similarity with its mouse and human resistin
homologs, and, interestingly, it comprises the signal peptide
for secretion (Fig. 1C). Thus, the new resistin form could
represent a non-secretable variant molecule generated by al-
ternative splicing of the rat resistin gene.
3.2. Analysis of the expression of resistin isoforms in adipose
tissue and during adipogenesis
RT-PCR from epididymal and retroperitoneal adipose tis-
sue RNA obtained from di¡erent animals shows appreciable
expression levels of the major resistin transcript using primers
at the standard concentration. In contrast, the S-resistin iso-
form appears as a band of slight intensity, being undetectable
in some samples (data not shown). In order to clarify whether
this pattern is due to a possible competence for primer bind-
ing, likely due to relative levels of transcripts, we performed
PCR under non-competitive conditions in presence of high
primer concentrations (see Section 2). Fig. 3A shows that
under these conditions the novel resistin transcript is observed
in all samples from epididymal and retroperitoneal fat tissue,
and it persists when restrictive PCR is performed (annealing
temperature until 80‡C) (data not shown).
Quantitative analysis of both ampli¢ed cDNAs under non-
competitive conditions is shown in Fig. 3B. It reveals that the
relative expression of both resistin isoforms is similar in epi-
didymal and retroperitoneal adipose tissues in all analyzed
individuals (Fig. 3A). The estimated relative proportion of
resistin and S-resistin cDNAs indicates that the expression
of resistin is 1.5-fold higher than that of S-resistin in both
adipose tissues (Fig. 3B). Interestingly, S-resistin transcript
is also present in brown adipose tissue (BAT) although in
lesser amounts than in WAT (Fig. 3C).
In addition, we have analyzed whether S-resistin expression,
like resistin, is regulated during adipogenesis. For that pur-
pose, we performed in vitro di¡erentiation of stroma vascular
preadipocytes isolated from rat WAT. RT-PCR assays for
resistin expression of RNA obtained from stroma vascular
preadipocytes and in vitro di¡erentiated adipocyte cells are
shown in Fig. 3C. These data show that resistin and S-resistin
expression levels are barely detectable in the stroma vascular
fraction but they increase during in vitro adipogenesis. The
levels of expression detected for both resistin isoforms in dif-
ferentiated cells are similar to that of WAT (Fig. 3C). Thus,
apparently, resistin and S-resistin expressions are induced dur-
ing adipogenesis.
3.3. S-resistin is localized into the nucleus
As S-resistin lacks secretion signal peptide we examined its
67 amino acid sequence searching for relevant signals for spe-
ci¢c intracellular localization. Although we could not ¢nd any
relevant signal for speci¢c targeting, using a PSORT II pro-
gram developed by Reinhardt and Hubbard [18], which dis-
criminates the tendency of a protein to be at either the nucleus
or the cytoplasm based on the amino acid composition, a
nuclear localization of S-resistin was predicted.
To test this likely di¡erential intracellular distribution be-
tween S-resistin and resistin, both alternatively spliced cDNAs
were tagged with FLAG epitope at the carboxy-terminus and
transiently expressed in COS-7, HEK-293T and 3T3-L1 cells
(Fig. 4). Western blot analysis con¢rmed the size of expressed
proteins. As shown in Fig. 4B, a unique band of expected
mass is detected with anti-FLAG antibody M2 in total lysates
obtained from HEK-293T cells transiently transfected with
each, pCMV5-S-res-FLAG or pCMV5-res-FLAG, expression
vector. For S-resistin-FLAG, a single product of about 7.5
kDa, according to its predicted ORF, is observed (Fig. 4B).
In agreement with previous reports [1,5,7], in resistin-FLAG-
transfected cells a unique peptide of about 10 kDa is found
(Fig. 4B), indicating that when the start AUG codon is
present, other downstream start codons are not used, in ac-
cordance with the scanning model of translation initiation. It
is therefore necessary that the splicing event occurs for the
translation of the S-resistin protein.
The precise intracellular distribution of resistin isoforms
was analyzed by staining COS-7 cells, transiently transfected
with pCMV5-S-res-FLAG or pCMV5-res-FLAG constructs,
with anti-FLAG antibodies. Fig. 4C shows positive COS-7
Fig. 3. Expression analysis of resistin isoforms in adipose tissues.
A: Expression of resistin and S-resistin was determined by RT-PCR
in both epididymal and retroperitoneal adipose tissues from four
3 months old rats, as indicated in Section 2. The ampli¢cation of a
356 bp fragment of L-actin is shown as control. B: Quanti¢cation
analysis of ampli¢ed products in epididymal (black box) and retro-
peritoneal (dashed gray box) tissues, was performed in each sample
as the ratio of ng of resistin or S-resistin cDNA ampli¢ed per ng
cDNA of L-actin under the reaction conditions used. Values are
meansWS.E.M. of four separate determinations per adipose tissue
type. C: Stroma vascular fraction from fat pads was subjected to in
vitro adipocyte di¡erentiation. RT-PCR was performed from cells
as well as from WAT and BAT RNAs. Actin ampli¢cation is shown
as control.
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Fig. 4. Rat resistin isoforms show di¡erent intracellular distribution. A: Structure of rat FLAG C-terminus-tagged resistin isoforms. For res-
FLAG the secretion signal is indicated. B: Western blot analysis for expressed resistin isoforms fused with FLAG epitope. HEK-293T cells
were harvested 48 h after the transfection, solubilized, and extracts (20 Wg of protein) were analyzed by immunoblotting with M2 anti-FLAG
antibody as described in Section 2 (1:2500 dilution). Values beside the lanes are molecular size markers in kDa. C and D: Subcellular localiza-
tion of Flag-tagged resistin isoforms in COS-7, HEK-293T and 3T3-L1 cells. Cells were transiently transfected with pCMV5-S-res-FLAG and
pCMV5-res-FLAG vectors, and direct immuno£uorescence was conducted with M2 anti-FLAG antibody. Anti-mouse £uorescein isothiocyanate
(FITC) was used as secondary antibody. C: Transfected COS-7 cells were co-stained with anti-FLAG (green panels), MitoTracker (red panels)
and Hoechst (blue panels). Also composed images are shown. Distribution of both resistin forms is clearly di¡erent, being predominantly nu-
clear for S-res-FLAG and cytoplasmic for res-FLAG. As shown, the resistin-FLAG pattern is not coincident with mitochondrial speci¢c Mito-
Tracker staining or nuclear signals. In contrast, using the S-res-FLAG construct, the most intense staining is detected into nucleus. Representa-
tive cells for each construct are shown. D: Transfected HEK-293T and 3T3-L1 cells co-stained with anti-FLAG and Hoechst. As shown, using
the S-res-FLAG construct, intense staining is detected into nucleus although a remarkable cytosolic staining is also detected in both cell lines.
At the contrary, the resistin-FLAG staining is exclusively cytosolic. In C and D scale bar is 20 Wm.
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cells for both resistin isoforms con¢rming their di¡erential
localization. For res-FLAG the expected pattern for a secre-
tion protein is obtained, with positive cells displaying a punc-
tuate cytoplasmic staining with intense signals in endoplasmic
reticulum and trans-Golgi network (Fig. 4C). No signal is
observed into the nucleus or into the cytosol. In sharp con-
trast, S-res-FLAG construct yields a quite di¡erent distribu-
tion. Although cytoplasmic staining can also be observed to
some extent, S-res-FLAG isoform is clearly enriched in the
nuclei of COS-7 cells (Fig. 4C). This cytoplasmic staining does
not resemble to secretion pattern of resistin and is not coin-
cident with signals of mitochondrial markers. Double staining
with MitoTracker (a mitochondrial speci¢c £uorescence dye)
and anti-FLAG antibody reveals a di¡erent pattern (Fig. 4C).
Only in some cells cytoplasmic anti-FLAG-positive structures
around MitoTracker-stained organelles are observed (indi-
cated by arrows in Fig. 4C). Nuclear staining is homogeneous
and the £uorescence does not penetrate into the nucleolus.
Labeling with Hoechst, which stained AT-rich DNA, demon-
strates a co-localization of nuclear S-res-FLAG and DNA
pattern (Fig. 4C, D). Similar results have been obtained using
HEK-293T and 3T3-L1 cells, con¢rming that this subcellular
targeting is not restricted to COS-7 cells (Fig. 4D). In HEK-
293T and 3T3-L1 cells we observe a more pronounced stain-
ing of cytoplasmic structures perhaps due to higher pCMV5-
S-res-FLAG expression in both cell lines than in COS-7 cells.
In accordance with that, immuno£uorescence analysis per-
formed 24 h after transiently transfection shows lower cyto-
solic signals than in cells analyzed after 48 h of transfection
(data not shown).
4. Discussion
Here we describe a novel shorter cDNA variant molecule of
rat resistin, that we have named S-resistin, generated by alter-
native splicing. Several authors have performed either RT-
PCR or Northern resistin analysis from rat adipose tissues,
but this S-resistin cDNA has not been described previously
[5,11,19,20]. It is possible that the S-resistin variant has not
been observed earlier due to its relative lower expression level
with respect to the resistin isoform. In fact, in our hands clear
S-resistin cDNA ampli¢cation by RT-PCR was only observed
when reactions were made under non-competitive conditions,
rising three-fold the primer concentration. Kim et al., using
Northern analysis, have reported the presence of two resistin
mRNA species of 1.4 and 0.8 kb in rat adipose tissues. These
were not produced by splicing but by di¡erent election of
polyadenylation site [5]. We detected that both, resistin and
S-resistin, use both polyadenylation signals. Therefore, it is
possible that the di¡erence between S-resistin and resistin
length is not enough to be detected by Northern analysis.
Here we report the ampli¢cation of S-resistin cDNA in
WAT, epididymal and retroperitoneal adipose tissues, and
BAT, suggesting that this isoform is functionally relevant
for both fat cell types.
The splicing event described herein eliminates the target
sequence for the secretion pathway, contained in the spliced
second exon, resulting in a new ORF that could generate a
shortened non-secretable isoform of 67 amino acids. Although
this minor isoform of rat resistin has not been detected in
adipose tissues in vivo, the isolation of this shortened
cDNA variant suggests that it could be functionally relevant
in adipose cells. Thus, in contrast to results obtained in pri-
mary culture of human preadipocytes and adipocytes [12], we
found that, as described for resistin in mice and rat [1,5],
S-resistin expression is induced during in vitro adipocyte dif-
ferentiation, suggesting that this new isoform could play an
important role in adipogenesis.
Interestingly, when S-resistin cDNA is overexpressed in cell
lines, a completely di¡erent cellular distribution from that of
resistin is observed, with S-res-FLAG-transfected cells show-
ing a predominant nuclear staining. Although sequence anal-
ysis predicted a preferential nuclear versus cytoplasmic local-
ization, this nuclear pattern was unexpected because the
S-resistin sequence lacks a de¢ned nuclear localization signal.
Nevertheless, this S-resistin nuclear distribution could be due
to its low molecular weight. Molecules of less than 30^40 kDa
can pass passively through the nuclear pore complex [21]. If
di¡usion was followed by intranuclear binding it would result
in nuclear accumulation [22]. According to that, S-resistin
nuclear accumulation seems to be a saturable process, so
that when S-resistin-transfected cells show higher protein lev-
els, increased cytoplasmic S-resistin signals are also observed.
Although we do not know yet the signi¢cance of nuclear
localization for resistin function, several evidences have been
developed over recent years indicating that some peptide hor-
mones and growth factors can function in the intracellular
space after internalization or directed retention within the
cells where they were synthesized [23]. Similarly to resistin,
for some growth factors alternative forms with nuclear local-
ization have been described. The most widely characterized
secreted proteins located into the nucleus are ¢broblastic
growth factor 2 (FGF-2) and parathyroid hormone-related
peptide (PTHrP) whose nuclear forms are translated from
in-frame non-AUG start sites [24,25]. Another example is ES-
kine/CCL27, a novel L-chemokine that is di¡erentially spliced
to produce secretable and nuclear targeted isoforms [26]. The
alternative nuclear isoform lacks the signal peptide and is
translocated to the nucleus and when overexpressed in 3T3
cells causes cytoskeletal rearrangements [27].
No equivalent alternative spliced isoform to S-resistin has
been described in other species. It is possible that in other
mammals, like humans and mice, alternative mechanisms
such as presence of non-AUG start sites, post-transductional
processing or internalization of both ligand and active recep-
tor into the cell nucleus, would account for generating a nu-
clear targeted resistin [23,25].
On the other hand, all members of the RELM family
present at the C-terminal region a cysteine-rich domain con-
taining 10 conserved cysteine residues that are likely involved
in intramolecular disul¢de bonds that de¢ne the conserved
structure of RELMs. Another cysteine residue, Cys26, present
in resistin and RELML, but not in RELMK, has been de-
scribed as necessary for homodimerization [28,29]. It has
been suggested that, like other hormone factors, RELM oli-
gomerization is necessary for ligand-induced receptor activa-
tion [30^32]. In S-resistin, the alternative splicing eliminates
this Cys26 conserving the C-terminal cysteine domain. Since
S-resistin seems to be a non-secretable protein, it is possible
that oligomerization is not necessary for its physiological
function and, therefore, S-resistin could act into the nucleus
as a monomeric molecule. Moreover, as described by Chen et
al. [29], the RELM family members can also interact with
each other regardless of the presence of Cys26 through non-
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covalent interactions. Since both resistin and S-resistin are
adipose-speci¢c molecules, this raises the possibility of inter-
actions between these two related RELMs.
Although the molecular identity of RELM receptors re-
mains unknown, resistin as well as RELMK and RELML
have been described as circulating hormones with a paracrine
and autocrine function on adipose tissue. The existence of a
non-secretable resistin isoform opens the possibility that intra-
cellular resistin could exert at least part of its biological e¡ects
via intracrine actions at the level of the nucleus. However,
further studies are required to understand the function of
this protein.
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